| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 700/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Enhance Memory Nootropics Pramiracetam Powder Pramiracetam
| Product Name | Pramiracetam |
| Appearance | White Powder |
| CAS No . | 68497-62-1 |
| MF | C14h27n3o2 |
| MW | 367.46156 |
Alzheimer's disease is a chronic progressive disease characterized by intellectual decline, significant changes in behavior and personality, accompanied by systemic tissue and organ decline, including cerebrovascular dementia, Alzheimer's dementia, mixed dementia, and other types. 50% to 70% of them are Alzheimer's disease. In recent years, the incidence rate of Alzheimer's disease has increased year by year with the aging of the world population, so the research and development of anti Alzheimer's drugs has important practical significance. Praxitan is a pyrrolidone based brain metabolism improving drug, which is a central nervous system drug that can improve memory and anti forgetfulness. It was developed by Parke Davis Pharmaceutical Company in the United States and has strong abilities to improve brain function, enhance memory, and promote brain agility. Clinical trials have shown that its activity is 6-13 times that of piracetam (brain rehabilitation), 3-4 times that of oxiracetam, and 1.25 times that of aniracetam. It has low toxicity and good tolerance, and can be used for long-term medication to improve symptoms and delay Alzheimer's dementia. Clinically applicable for the prevention of attention and memory disorders, benign aging forgetfulness, and Alzheimer's disease in the elderly, enhancing memory. Praxitan is also used as an additive in vasodilator health products for.
){kind=link}